Copyright
©The Author(s) 2021.
World J Gastroenterol. Aug 21, 2021; 27(31): 5247-5258
Published online Aug 21, 2021. doi: 10.3748/wjg.v27.i31.5247
Published online Aug 21, 2021. doi: 10.3748/wjg.v27.i31.5247
Figure 1 Flow chart.
TT: Tailored therapy; CT: Concomitant regimen; S: Sensitive; R: Resistance; PAC: Pancreatic adenocarcinoma; PBMT: Bismuth-containing quadruple combination; ITT: Intention-to-treat; PP: Per-protocol; H. pylori: Helicobacter pylori.
- Citation: Choi YI, Chung JW, Kim KO, Kwon KA, Kim YJ, Kim JH, Seo JY, Park DK. Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients. World J Gastroenterol 2021; 27(31): 5247-5258
- URL: https://www.wjgnet.com/1007-9327/full/v27/i31/5247.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i31.5247